Eventide Asset Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-853,800
| Closed | -$25.3M | – | 151 |
|
|
2022
Q4 | $25.3M | Hold |
853,800
| – | – | 0.5% | 66 |
|
|
2022
Q3 | $19.9M | Hold |
853,800
| – | – | 0.39% | 75 |
|
|
2022
Q2 | $14.3M | Sell |
853,800
-409,671
| -32% | -$6.87M | 0.31% | 83 |
|
|
2022
Q1 | $55.4M | Hold |
1,263,471
| – | – | 0.87% | 41 |
|
|
2021
Q4 | $76.9M | Buy |
1,263,471
+100,000
| +9% | +$6.09M | 0.98% | 36 |
|
|
2021
Q3 | $48.4M | Hold |
1,163,471
| – | – | 0.64% | 51 |
|
|
2021
Q2 | $35.3M | Buy |
1,163,471
+751,633
| +183% | +$22.8M | 0.47% | 65 |
|
|
2021
Q1 | $12.3M | Buy |
+411,838
| New | +$12.3M | 0.18% | 110 |
|